Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$15.82 +0.26 (+1.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Interest & Investment Income (2018)

Arcturus Therapeutics Holdings' (ARCT) quarterly Interest & Investment Income came in at -$4000.0 in Q4 2018, down 300.0% on a QoQ basis from $2000.0 in Q3 2018.

Analysis

Arcturus Therapeutics Holdings (ARCT) Interest & Investment Income (2018) Analysis & Trends

Arcturus Therapeutics Holdings (ARCT) has 1 years of Interest & Investment Income data on file, last reported at -$4000.0 in Q4 2018.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Arcturus Therapeutics Holdings 449.65 Mn 258.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -4,000.00
Sep 30, 2018 2,000.00
Jun 30, 2018 7,000.00